我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

腔内修复术与药物治疗胸降主动脉穿透性溃疡近远期疗效分析

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第5期
页码:
573-576
栏目:
临床研究
出版日期:
2015-05-05

文章信息/Info

Title:
Short- and long-term efficacy of endovascular repair and medical treatment of penetration aortic ulcer
作者:
史亚娜; 杜占奎; 王 雅; 王效增
(沈阳军区总医院全军心血管病研究所心内科，辽宁 沈阳 110016)
Author(s):
SHI Ya-na;  DU Zhan-kui;  WANG Ya;  WANG Xiao-zeng
(Department of Cardiology, PLA Cardiovascular Research Institute, Shenyang 110016, Liaoning, China)
关键词:
主动脉穿透性溃疡; 腔内修复术; 药物治疗; 临床疗效
Keywords:
penetration aortic ulcer;  endovascular aneurysm repair;  medical treatment;  curative effect
分类号:
R543.16
DOI:
-
文献标识码:
A
摘要:
目的 对比评价腔内修复术(EVAR)与药物治疗（MT）对胸降主动脉穿透性溃疡(PAU)的近、远期疗效。方法 观察2006年3月~2014年3月住院的85例PAU患者，根据治疗方式分为EVAR组（47例）和MT组（38例），EVAR组在强化药物治疗基础上行EVAR治疗，MT组单纯行药物强化治疗，随访观察2组间近期、远期的肢体缺血、截瘫、肾功能衰竭、脑卒中、新发主动脉夹层、死亡等不良事件的发生情况。结果 EVAR组患者47例手术均成功，术中无内漏、支架移位、主动脉破裂死亡及脑卒中等发生。首次入院至30 d随访，2组随访率均为100%，2组无截瘫、脑卒中及死亡事件发生。EVAR组肢体缺血、肾功能衰竭的发生率均略低于MT组，但差异均未达到显著性水平（0 vs. 10%，2% vs. 5%）。MT组新发主动脉夹层发生率显著高于EVAR组（16% vs. 0%，P<0.01）。2组远期随访时间、随访率差异无统计学意义〔（34±22）个月 vs.（32±23）个月，87% vs. 82%〕。远期随访2组间均无截瘫发生，MT组肢体缺血、肾功能衰竭的发生率均略高于EVAR组，但差异均未达到显著水平（16% vs. 2%;13% vs. 5%）。EVAR组总的病死率及主动脉破裂病死率均略低于MT组，但2组间差异均未达到显著水平（5% vs. 13%；2% vs. 6%）。结论 与MT相比，EVAR治疗PUA , 可降低近、远期主动脉夹层的发生率。
Abstract:
AIM To evaluate the short- and long-term clinical efficacy of endovascular repair (EVAR) and medical treatment (MT) in penetration aortic ulcer (PAU). METHODS Eighty-five PAU patients diagnosed from March 2006 to March 2014 were divided into EVAR group in which 47 patients received EVAR plus MT and MT group in which 38 patients received MT only. Short- and long-term clinical events including limb ischemia, paraplegia, renal failure, cerebral ischemia, dissection and death were evaluated in both groups. RESULTS In EVAR group, EVAR was successful in all 47 cases, and no endoleaks, stent migration, aortic rupture and cerebral ischemia occurred during operation. During the 30-day in-hospital follow-up, no negative events including paraplegia, cerebral ischemia and death occurred. The rate of limb ischemia and renal failure in EVAR group was lower than in the MT group, but no significant difference was observed between groups, (0 vs. 10%; 2% vs. 5%). However, the rate of dissection in the MT group was significantly higher than in the EVAR group (16% vs. 0, P=0.006). There was no statistical difference in the mean time of long-term follow-up between groups ［(34±22) months vs.(32±23) months; 87% vs. 82］. No paraplegia occurred, but the cumulative events of limb ischemia and renal failure in MT group were higher (16% vs. 2%; 13% vs. 5%). No statistical difference was found in the cumulative mortality and rupture rate between groups; however, these events in EVAR group were lower than those in MT group (5% vs. 13%; 2% vs. 7%). CONCLUSION Compared with MT alone, endovascular repair can decrease cumulative morality and rate of dissection in treatment of penetration aortic ulcer.

参考文献/References

[1]Pate JW,Cole Jr FH,Walker WA,et al.Penetrating injuries of the aortic arch and its branches[J].Ann Thorac Surg,1993,55(3):586-592.
[2]Carpenter SW,Kodolitsch YV,Debus ES,et al.Acute aortic syndromes: definition, prognosis and treatment options[J].J Cardiovasc Surg(Torino),2014,55(2):133-144.
[3]Ganaha F,Miller DC,Sugimoto K,et al.Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer a clinical and radiological analysis[J].Circulation,2002,106(3) 342-348.
[4]Pokrovskiǐ AV,Vafina GR.Angiol Sosud Khir.Penetrating atherosclerotic ulcers of the aorta[J].Angiol Sosud Khir,2012,18(4):8-14.
[5]Hanna JM,Andersen ND,Ganapathi AM,et al.Five-year results for endovascular repair of acute complicated type B aortic dissection[J].J Vasc Surg,2014,59(1):96-106.
[6]Nienaber CA,Kische S,Rousseau H,et al.Endovascular repair of type B aortic dissection:long-term results of the randomized investigation of stent grafts in aortic dissection trial[J].Circ Cardiovasc Interv,2013,6(4):407-416.
[7]Nathan DP,William B,Lai E,et al.Presentation,complications,and natural history of penetrating atheroscleroticulcer disease[J].J Vasc Surg,2012,55(1):10-15.
[8]Brooke BS,Habashi JP,Judge DP,et al.Angiotensin II blockade and aortic-root dilation in Marfan’ s syndrome[J].N Engl J Med,2008,358(1):2787-2795.

备注/Memo

备注/Memo:
收稿日期：2014-11-11.
基金项目：辽宁省科技计划项目基金资助(2012225009)
通讯作者：王效增，主任医师，主要从事冠心病及外周血管介入治疗研究 Email：wxiaozeng @163.com
作者简介：史亚娜，主治医师 Email：1355245926@qq.com
更新日期/Last Update: 2015-04-28